Million Veteran Program lends statistical power to assess genetic risk.
Vanderbilt-UCSF entry among 15 dialysis innovations advancing in national accelerator competition.
Lessons and challenges from a national authority’s 40-year career.
Oncologist Nancy Davis, M.D., reports to the AUA on need for separate signatures and therapies for rarer variants.
Volume dynamics challenge traditional understanding of the disease.
1 / 5
New insights into the evolution of multicellularity and how rare renal diseases developed.
Study elucidates the fibrotic pathway, paving the way for targeted therapies.
New meta-analysis integrates seven genome-wide association studies to explain FGF23 elevations.